trending Market Intelligence /marketintelligence/en/news-insights/trending/I3-aU70IKxrhaIV6ptVB1w2 content esgSubNav
In This List

Haba Laboratories fiscal Q1 loss widens YOY

Blog

Capital Markets Activity Infographic: SPAC Volume Rises in Q3; Equity Issuance Drops but Remains Strong in Several Sectors

Blog

Asset Owner Perspectives on Climate Change Measurement, Management, and Reporting in Australia

Blog

How Financial Institutions are Managing Exposure to U.S. Municipals

Blog

Insight Weekly: Global stock performance; hydrogen pilot projects; Powell's Fed future unsure


Haba Laboratories fiscal Q1 loss widens YOY

Haba Laboratories Inc. said its normalized net income for the fiscal first quarter ended June 30 was a loss of ¥37.81 per share, compared with a loss of ¥13.03 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of ¥148.8 million, compared with a loss of ¥51.3 million in the prior-year period.

The normalized profit margin fell to negative 5.6% from negative 1.8% in the year-earlier period.

Total revenue fell 6.4% on an annual basis to ¥2.66 billion from ¥2.84 billion, and total operating expenses came to ¥2.89 billion, compared with ¥2.91 billion in the year-earlier period.

Reported net income totaled a loss of ¥199.0 million, or a loss of ¥50.59 per share, compared to a loss of ¥99.0 million, or a loss of ¥25.17 per share, in the prior-year period.

As of Aug. 14, US$1 was equivalent to ¥102.44.